arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

West Pharmaceutical Services, Inc.

WST Health Care Medical/Dental Instruments
$394.03
▲ +1.4% Today
as of Oct 22, 16:53 ET
Last 30 days +10.93% Sep 14 → Oct 22
$352.09 $363.35 $374.62 $385.88 $397.14 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$394.15
High
$397.15
Low
$389.17
Volume
$679,884
Avg Vol
$785,448
Mkt Cap
$25.8B
P/E (TTM)
64.11
Beta
—
52w High
$397.15
52w Low
$223.83
Div Yield
—
Shares Out
$70M

Recent Press Releases & News last 60 days · 23 items

mixed ▲ 1 ● 12 ▼ 1
Oct 21 · 12:29 Zacks
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
Oct 19 · 22:04 PR PR Newswire
West Declares Quarterly Dividend
Oct 15 · 12:25 Zacks
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally?
▸ Show all 23 press releases & news Free account →

WST earnings at a glance

The options market is pricing a move of about ±3.1% after the report, a range of roughly $381.78 to $406.28 from today's $394.03. Over its last 6 reports the stock rose the next day 3 times and fell 3, moving ±8.6% on average; after the most recent report on Jul 23, 2026 it moved -0.8%. That means options currently expect less movement than WST has typically delivered. WST beat the consensus EPS estimate in 6 of its last 6 reported quarters. Implied volatility is currently 26%. The share price of $394.03 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$224
$397
98% of range
Avg surprise (last 6)
+18.4%
Avg reaction (last 6)
+6.9%
50% positive
Latest IV / EM
26%
EM ±3.1% · $370 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$1.22$1.51$1.79$2.08$2.37 Actual $1.85Actual $2.06Actual $2.14Actual $1.55Actual $1.51Actual $1.85Actual $1.45Est $1.22Actual $1.84Est $1.51Actual $1.96Est $1.67Actual $2.04Est $1.83Actual $2.13Est $1.68Actual $2.37Est $2.08 MarJunSepMarJunSepMar/2025Jun/2025Sep/20258K8KJun/2026
Revenue vs Net Income Revenue Net income
$0$229M$458M$687M$916M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu Jul 23, 2026Jun/2026 $2.37 $2.08 +13.9% +13.0% -0.8% earnings
Thu Apr 23, 20268K 2026-04-23 $2.13 $1.68 +26.8% — +12.9% earnings
Thu Feb 12, 20268K 2026-02-12 $2.04 $1.83 +11.5% — -1.0% earnings
Thu Oct 23, 2025Sep/2025 $1.96 $1.67 +17.4% — +10.9% earnings
Thu Jul 24, 2025Jun/2025 $1.84 $1.51 +21.9% — +22.8% earnings
Thu Apr 24, 2025Mar/2025 $1.45 $1.22 +18.9% — -3.5% earnings
Mon Sep 30, 2024Sep 2024 $1.85 — — — — financials
Sun Jun 30, 2024Jun 2024 $1.51 — — — — financials
Sun Mar 31, 2024Mar 2024 $1.55 — — — — financials
Sat Sep 30, 2023Sep 2023 $2.14 — — — — financials
Fri Jun 30, 2023Jun 2023 $2.06 — — — — financials
Fri Mar 31, 2023Mar 2023 $1.85 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$872M$845M—$805M$766M$698M—$747M
Cost of revenue$543M$548M—$510M$493M$466M—$482M
Gross profit$329M$296M—$294M$274M$232M—$265M
Operating income$179M$177M—$168M$154M$107M—$161M
Net income$154M$139M—$140M$132M$90M—$136M
EPS (diluted)$2.15$1.92—$1.92$1.82$1.23—$1.85

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$436M$521M$791M$628M$510M$404M$485M$491M
Inventory$447M$453M$444M$438M$421M$389M$377M$401M
Total current assets$1.81B$1.83B$1.98B$1.82B$1.68B$1.46B$1.54B$1.55B
Total assets$4.08B$4.11B$4.27B$4.11B$3.95B$3.62B$3.64B$3.68B
Long-term debt$203M$203M$203M$203M$203M$203M$203M$203M
Total liabilities$1.09B$1.12B$1.09B$1.05B$1.02B$935M$961M$923M
Total equity$2.99B$2.99B$3.18B$3.05B$2.93B$2.68B$2.68B$2.75B

Implied volatility — last 90 days

22%32%42%52%62% Jun 07 — IV 39% · EM ±5.3%Jun 08 — IV 37% · EM ±4.9%Jun 09 — IV 37% · EM ±4.6%Jun 10 — IV 35% · EM ±4.2%Jun 11 — IV 33% · EM ±3.7%Jun 12 — IV 33% · EM ±3.3%Jun 15 — IV 37% · EM ±2.7%Jun 16 — IV 40% · EM ±2.4%Jun 17 — IV 63% · EM ±2.6%Jun 19 — IV 30% · EM ±6.7%Jun 22 — IV 32% · EM ±6.7%Jun 23 — IV 30% · EM ±6.2%Jun 24 — IV 32% · EM ±6.3%Jun 25 — IV 30% · EM ±5.9%Jun 26 — IV 30% · EM ±5.8%Jun 29 — IV 31% · EM ±5.5%Jun 30 — IV 32% · EM ±5.5%Jul 01 — IV 31% · EM ±5.1%Jul 02 — IV 29% · EM ±4.6%Jul 03 — IV 30% · EM ±4.6%Jul 06 — IV 31% · EM ±4.3%Jul 07 — IV 31% · EM ±4.2%Jul 08 — IV 35% · EM ±4.4%Jul 09 — IV 32% · EM ±3.7%Jul 10 — IV 31% · EM ±3.4%Jul 13 — IV 35% · EM ±2.9%Jul 14 — IV 36% · EM ±2.6%Jul 15 — IV 37% · EM ±2.2%Jul 16 — IV 40% · EM ±1.7%Jul 20 — IV 47% · EM ±11.2%Jul 21 — IV 46% · EM ±10.7%Jul 22 — IV 46% · EM ±10.5%Jul 23 — IV 30% · EM ±6.7%Jul 24 — IV 30% · EM ±6.6%Jul 27 — IV 31% · EM ±6.5%Jul 28 — IV 30% · EM ±6.2%Jul 29 — IV 31% · EM ±6.2%Jul 30 — IV 29% · EM ±5.7%Jul 31 — IV 29% · EM ±5.6%Aug 03 — IV 31% · EM ±5.5%Aug 04 — IV 29% · EM ±5.0%Aug 05 — IV 27% · EM ±4.5%Aug 06 — IV 29% · EM ±4.7%Aug 07 — IV 26% · EM ±4.1%Aug 10 — IV 28% · EM ±3.8%Aug 11 — IV 28% · EM ±3.8%Aug 12 — IV 27% · EM ±3.4%Aug 13 — IV 26% · EM ±3.0%Aug 14 — IV 27% · EM ±3.0%Aug 17 — IV 30% · EM ±2.5%Aug 18 — IV 34% · EM ±2.5%Aug 19 — IV 28% · EM ±1.6%Aug 20 — IV 42% · EM ±1.8%Aug 24 — IV 26% · EM ±5.4%Aug 25 — IV 25% · EM ±5.2%Aug 26 — IV 26% · EM ±5.1%Aug 27 — IV 26% · EM ±5.0%Aug 28 — IV 25% · EM ±4.7%Aug 31 — IV 26% · EM ±4.6%Sep 01 — IV 26% · EM ±4.4%Sep 02 — IV 26% · EM ±4.3%Sep 03 — IV 24% · EM ±3.9%Sep 04 — IV 23% · EM ±3.6%Sep 07 — IV 26% · EM ±3.6%Sep 08 — IV 27% · EM ±3.6%Sep 09 — IV 28% · EM ±3.5%Sep 10 — IV 29% · EM ±3.4%Sep 11 — IV 33% · EM ±3.7%Sep 14 — IV 30% · EM ±2.5%Sep 15 — IV 35% · EM ±2.6%Sep 16 — IV 42% · EM ±2.5%Sep 17 — IV 35% · EM ±1.4%Sep 21 — IV 25% · EM ±5.2%Sep 22 — IV 24% · EM ±4.9%Sep 23 — IV 24% · EM ±4.9%Sep 24 — IV 25% · EM ±5.0%Sep 25 — IV 23% · EM ±4.5%Sep 28 — IV 24% · EM ±4.2%Sep 29 — IV 23% · EM ±3.9%Sep 30 — IV 24% · EM ±3.9%Oct 01 — IV 24% · EM ±3.9%Oct 02 — IV 25% · EM ±3.9%Oct 06 — IV 22% · EM ±3.0%Oct 07 — IV 23% · EM ±2.8%Oct 08 — IV 26% · EM ±3.1%

Sector peers

RMD
ResMed Inc.
$31.8B $253.06+3.1%
DXCM
DexCom, Inc.
$31.8B $78.32-8.7%
SOLV
Solventum Corporation
$14.6B $87.45+1.2%
PEN
Penumbra, Inc.
$12.5B $324.96+0.2%
BAX
Baxter International Inc.
$12.4B $25.65+4.7%
GKOS
Glaukos Corporation
$10.2B $176.69+1.9%

WST earnings FAQ

What is WST's expected move for earnings?

Options currently price a move of about ±3.1%, or $12.25 per share either way from $394.03.

How does WST stock usually react to earnings?

Across the last 6 reports the average next-day move was ±8.6%, up 3 times and down 3 times.

What is WST's implied volatility?

WST's at-the-money implied volatility is about 26% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in